High-Throughput Safety Signal Detection for Sodium-Glucose Cotransporter-2 Inhibitors in Type 2 Diabetes
Preprint
Abstract
Objective To systematically identify potential safety signals associated with sodium-glucose cotransporter-2 inhibitors (SGLT2i) in patients with type 2 diabetes (T2D) using a high-throughput target trial emulation pipeline applied to real-world data. Methods We utilized electronic health record (EHR) data from the OneFlorida+ Data Trust (2012–2023). Using a retrospective new-user cohort design, we compared SGLT2i initiators to initiators of other second-line glucose-lowering drugs (GLDs). We evaluated risk across all ICD-10-CM 4-digit diagnosis codes. A semi-Bayesian shrinkage method was employed to adjust hazard ratios (HR) and p-values to account for multiple testing and stabilize estimates for rare outcomes. Results The analysis identified several statistically significant safety signals. Validating our method, we observed known adverse events such as candidiasis of the vulva and vagina (HR=1.64) and other urogenital fungal infections. We also detected potential signals for conditions such as viral conjunctivitis and melanocytic nevi. Conclusion This high-throughput screening effectively identified both known and potential new safety signals for SGLT2i. The use of semi-Bayesian shrinkage provides a robust framework for post-marketing surveillance in large healthcare databases.Keywords
This publication has 10 references indexed in Scilit:
- A review of the safety of sodium‐glucose co‐transporter‐2 inhibitorsDiabetes, Obesity and Metabolism, 2025
- 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2022Diabetes Care, 2021
- Empirical confidence interval calibration for population-level effect estimation studies in observational healthcare dataProceedings of the National Academy of Sciences of the United States of America, 2018
- Adverse events with sodium-glucose co-transporter-2 inhibitors: A global analysis of international spontaneous reporting systemsNutrition, Metabolism and Cardiovascular Diseases, 2017
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 DiabetesNew England Journal of Medicine, 2016
- Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studiesStatistics in Medicine, 2015
- Empirical Performance of a New User Cohort Method: Lessons for Developing a Risk Identification and Analysis SystemDrug Safety, 2013
- Empirical Performance of a Self-Controlled Cohort Method: Lessons for Developing a Risk Identification and Analysis SystemDrug Safety, 2013
- Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity‐score matched samplesStatistics in Medicine, 2009
- Bayesian perspectives for epidemiological research. II. Regression analysisInternational Journal of Epidemiology, 2007